|
Jan 31
|
Novartis Pares Gains As Its Bread-And-Butter Drug Faces Looming Competition
|
|
Jan 31
|
Novartis Ag (NVS) Q4 2024 Earnings Call Transcript
|
|
Jan 31
|
Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Jan 31
|
Health Care Roundup: Market Talk
|
|
Jan 31
|
Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb
|
|
Jan 31
|
Novartis Q4 Earnings: Revenue And EPS Beat, CEO Dismisses Entresto Patent Expiration Worries
|
|
Jan 31
|
Trending tickers: Apple, Intel, Novartis, Shell, Smiths Group
|
|
Jan 31
|
Novartis Expects Further Profit, Sales Growth Despite Competition Threat
|
|
Jan 31
|
Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024
|
|
Jan 31
|
Chevron earnings, December PCE, FedSpeak: What to Watch
|